Metastatic Colorectal Cancers Withdrawn Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02085005Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal CancerTreatment
NCT02345746Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver MetastasisTreatment
NCT02079220A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal CancerTreatment
NCT01175291FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal CancerTreatment
NCT01293942IXO+A in mCRC With Liver-only MetastasesTreatment
NCT01889680Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal CancerTreatment